Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Boltzmann Labs logo — Accelerating Drug Discovery using AI

Boltzmann Labs

Accelerating Drug Discovery using AI

Founded 2019 India Hyderabad, India 38 employees

General Information

Company Name Boltzmann Labs
Founded Year 2019
Location India Hyderabad, India
Employees 38
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Tiered Pricing, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Boltzmann Labs. To contact Boltzmann Labs, visit boltzmann.co.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Boltzmann Labs compare?

A PDF of Boltzmann Labs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Boltzmann Labs soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Product Launch Nov 05, 2026

Boltzmann Labs launched Agent Scientist, featuring a scientific hackathon series.

Growth Metrics Nov 03, 2026

Boltzmann Labs' Agent Scientist successfully executed 3 simulation replicas extended to 30 ns each.

New Partnership Nov 02, 2026

Boltzmann Labs partnered with ChembioAI to power the SciSprint 2026 hackathon series.

Boltzmann Labs a competitor of yours? Have our desk watch it

About Boltzmann Labs

Boltzmann Labs, founded in 2019, is on a mission to revolutionize drug discovery through cutting-edge AI technology. With a slogan of "Accelerating Drug Discovery using AI," the company seeks to transform the healthcare industry by providing precision medicine solutions.

Boltzmann Labs operates in the biotech sector, although specific industries are not detailed. Leveraging AI-enabled technologies, the company offers a comprehensive suite of products and services across the drug discovery spectrum. These include target and biomarker identification, small molecule and antibody design, protein engineering, and custom synthesis planning, catering to a wide range of pharmaceutical needs.

The company’s innovative approach promises to optimize and accelerate the drug discovery process. Despite lacking specified past investments and headquarters details, Boltzmann Labs' vision positions it as a potential leader in AI-driven biotech innovations for investors looking to delve into transformative healthcare solutions.

Business keywords: Drug Discovery, Precision Medicine, Data-driven Solutions, Target Identification, Biomarker Identification, Small Molecule Design, Antibody Design, Protein Engineering, Custom Synthesis Planning, AI-powered Technologies, Bioinformatics, Medicinal Chemistry, Deep Learning, Retrosynthesis

Services & Products

AI-Powered Research
Molecular Design Automation
Property Prediction
Retrosynthesis Planning
Lab Execution Automation

Target Customers

Pharmaceutical Companies Biotech Firms Research Institutions Chemists R&D Departments

No funding data available for Boltzmann Labs yet.

Boltzmann Labs Alternatives & Competitors

Boltzmann Labs vs
AIGEN Sciences Inc.
AIGEN Sciences Inc. Korea South

AI-Driven Drug Generation

14 employees
Biotechnology, Pharmaceutical
Boltzmann Labs vs
Arcus Biosciences
Arcus Biosciences United States

Biopharmaceutical company developing differentiated molecules and combination therapies for cancer a...

IPO
633 employees
Biopharma, Biotechnology
Boltzmann Labs vs
Nostrum Biodiscovery
Nostrum Biodiscovery Spain

One step ahead in molecular design

Seed
46 employees
Biotechnology

FAQ About Boltzmann Labs

Accelerating Drug Discovery using AI
Boltzmann Labs was founded in 2019.
Boltzmann Labs is headquartered in Hyderabad, India.
Boltzmann Labs has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Tiered Pricing and Usage Based.
Boltzmann Labs has approximately 38 employees.
Boltzmann Labs offers: AI-Powered Research, Molecular Design Automation, Property Prediction, Retrosynthesis Planning, Lab Execution Automation.
Top alternatives and competitors to Boltzmann Labs include AIGEN Sciences Inc., Arcus Biosciences, Nostrum Biodiscovery, Synbio Technologies, Novalix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Boltzmann Labs and AIGEN Sciences Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Boltzmann Labs, https://bouncewatch.com/company/boltzmann-labs, updated 6 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout